Heejin Y. Yoo

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Integrative analysis of AT classification, plasma biomarkers, and cognitive trajectories across diverse dementia syndromes.

Integrative analysis of AT classification, plasma biomarkers, and cognitive trajectories across diverse dementia syndromes.

Journal: Scientific reports

Published: July 26, 2025

Glymphatic dysfunction links vascular pathology to Alzheimer's biomarkers and cognitive decline.

Glymphatic dysfunction links vascular pathology to Alzheimer's biomarkers and cognitive decline.

Journal: Alzheimer's research & therapy

Published: May 13, 2025

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Journal: Clinical nuclear medicine

Published: April 12, 2025

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups.

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups.

Journal: Alzheimer's research & therapy

Published: April 09, 2025

A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models.

A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models.

Journal: Archives of pharmacal research

Published: March 10, 2025

Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 20, 2025

Corrigendum to "Brain Metabolic Resiliencein Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia [Am J of Geriatric Psychiatry (2024) in press, 1-11].

Corrigendum to "Brain Metabolic Resiliencein Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia [Am J of Geriatric Psychiatry (2024) in press, 1-11].

Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

Published: January 30, 2025

Tailoring thresholds for interpreting plasma p-tau217 levels.

Tailoring thresholds for interpreting plasma p-tau217 levels.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 17, 2025

Correction: Different associations between body mass index and Alzheimer's markers depending on metabolic health.

Correction: Different associations between body mass index and Alzheimer's markers depending on metabolic health.

Journal: Alzheimer's research & therapy

Published: December 02, 2024

Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics.

Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 30, 2024

Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.

Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: July 09, 2024

Different associations between body mass index and Alzheimer's markers depending on metabolic health.

Different associations between body mass index and Alzheimer's markers depending on metabolic health.

Journal: Alzheimer's research & therapy

Published: June 02, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026